Status:
RECRUITING
Innovation for Small-scale Experiments: ReceptIVFity Test
Lead Sponsor:
Erasmus Medical Center
Collaborating Sponsors:
The Dutch Healthcare Authority
Conditions:
Pregnancy Related
Infertility, Female
Eligibility:
FEMALE
18-42 years
Phase:
NA
Brief Summary
The ReceptIVFity acts as a timing-tool for prediction of optimal pregnancy chances and provides insight into the patient's current (two months after sampling) success rate of an IVF/IVF-ICSI treatment...
Eligibility Criteria
Inclusion
- Naïve IVF or IVF/ICSI patients
- Indication for an IVF or IVF-ICSI procedure.
- 18 years \< age \< 43 years.
- Willing to provide a vaginal swab with the ReceptIVFity test.
- Willing to provide informed consent.
Exclusion
- The use of hormonal contraceptives at the time of taking the test.
- The use of antibiotic treatment at the time of taking the test.
- Emergency IVF for cancer or other reasons.
- Women with endometriosis pre-treated with an Gn-RH analogue.
- Women having IVF for egg preservation reasons.
Key Trial Info
Start Date :
September 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
683 Patients enrolled
Trial Details
Trial ID
NCT06051201
Start Date
September 4 2023
End Date
September 1 2027
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasmus University Medical Center
Rotterdam, Netherlands, 3015GD